Stocks and Investing Stocks and Investing
Wed, August 8, 2018
Tue, August 7, 2018

Matteis Paul Initiated (ACAD) at Hold and Held Target at $17 on, Aug 7th, 2018


Published on 2024-10-26 07:44:16 -
  Print publication without navigation


Matteis Paul of Stifel, Initiated "ACADIA Pharmaceuticals Inc." (ACAD) at Hold and Held Target at $17 on, Aug 7th, 2018.

Matteis, nor any peers, have made any analyst calls on ACAD in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30